Safety and Tolerability of an Antibody Against Zika Virus (Tyzivumab) in ZIKV Infected Patients
Condition: Treatment of Acute Zika Virus Infection Interventions: Biological: Tyzivumab; Other: Placebo Sponsors: Tychan Pte Ltd.; Singapore Clinical Research Institute; Duke-NUS Graduate Medical School Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Zika Virus